Renal Hemodynamic Effects of RLX030A in Subjects With Chronic Heart Failure (CHF)
Clinical trial NCT01546532 · COMPLETED
Trial details
- NCT number
- NCT01546532
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-02-01
- Primary completion
- 2012-12-01
- Enrollment
- 118
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.